Get started
HAEMATO AG NPV (POST SPLIT)HAEMATO AG NPV (POST SPLIT)HAEMATO AG NPV (POST SPLIT)

HAEMATO AG NPV (POST SPLIT)

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

0VZ7 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Haemato AG engages in the pharmaceutical industry. It focuses on growth markets of patent-free, and patented medicinal products in the insurance-financed market. Its portfolio include therapies for cancer, HIV, rheumatology, and other chronic diseases, and products for the privately financed market for aesthetic treatments. It operates through the Lifestyle and Aesthetics, and Specially Pharma segments. The company was founded on May 10, 1993 and is headquartered in Schönefeld, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
0VZ7 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company